Autoplaque vs Cardiac CT Function Software Application

Direct competitors — feature-level head-to-head below. Comparability 80/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cedars-Sinai Medical Center: AIM
VS
by Circle Cardiovascular Imaging

AI Verdict

Autoplaque is a specialized tool for quantitative analysis of coronary plaques and luminal stenoses, aiding in heart attack risk prediction. The Cardiac CT Function Software Application, while primarily focused on quantifying cardiac function metrics, also offers comprehensive coronary plaque analysis. Therefore, they are direct competitors for plaque analysis, with Tool B providing additional functional assessment capabilities.

Choose Autoplaque if…

Choose Autoplaque if your primary focus is on precise, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is specifically designed for detailed plaque characterization and stenosis measurement, aiding in accurate heart attack risk prediction and guiding targeted treatment decisions.

View Autoplaque →

Choose Cardiac CT Function Software Application if…

Choose Cardiac CT Function Software Application if you need a comprehensive evaluation of cardiac function in addition to coronary anatomy from CT angiography images. This tool leverages AI/ML to segment cardiac structures and quantify essential metrics such as ejection fraction and ventricular volumes, providing a holistic view of heart performance for diagnosis and monitoring.

View Cardiac CT Function Software Application →

When choosing between Autoplaque and Circle CVI’s Cardiac CT Function Software Application, physicians should consider their primary focus: detailed coronary plaque analysis versus comprehensive cardiac function assessment. Autoplaque, developed by Cedars-Sinai AIM, excels in quantitative analysis of coronary plaques and luminal stenoses from CT angiography (CTA) images. It provides detailed measurements of calcified, non-calcified, and low-attenuation plaque volumes, as well as stenosis percentages and remodeling indices, aiding in heart attack risk prediction and treatment guidance. It is a workstation-based post-processing application, running on Windows or Mac platforms.

In contrast, Circle Cardiovascular Imaging’s Cardiac CT Function Software Application, part of the cvi42 platform, utilizes AI/ML to analyze multi-phase, multi-slice cardiovascular CTA images for segmenting cardiac structures and quantifying key function metrics such as ejection fraction and volumes. While it also offers coronary plaque analysis (total, calcified, non-calcified, low attenuation), its core strength lies in its broader cardiac function assessment capabilities. The key practical difference is that Autoplaque is a dedicated plaque analysis tool, whereas Circle CVI’s offering is a more comprehensive platform that includes both plaque analysis and robust cardiac function quantification.

Therefore, a physician whose primary need is in-depth, AI-powered quantification of coronary plaque characteristics and stenosis for risk stratification should lean towards Autoplaque. Conversely, a physician requiring a more holistic view of cardiac health, encompassing both plaque assessment and detailed cardiac function metrics from CT, would find Circle CVI’s Cardiac CT Function Software Application more suitable due to its integrated platform approach.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Autoplaque Cardiac CT Function Software Application
Pricing Not disclosed Contact for pricing
Deployment Workstation-based software, runs on Windows or Mac computer platforms On-premise software, integrated into hospital or private practice environments. Server pulls DICOM data from PACS.
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiac CT Function Software Application

Tool B, the Cardiac CT Function Software Application, offers integrated reporting with infographics and screenshots, enhancing the clarity and ease of communicating diagnostic findings. Its vendor-neutral solution also suggests broader compatibility and adaptability across various clinical environments. While Tool A, Autoplaque, features automated segmentation, Tool B's comprehensive output and flexible integration give it an edge in overall user experience.

Clinical Value

Cardiac CT Function Software Application

Both tools are FDA-cleared and provide significant clinical utility. However, Tool B offers a broader range of quantitative metrics, encompassing both cardiac function (ejection fraction, volumes) and coronary plaque analysis within a single application. This comprehensive capability allows for a more holistic cardiac assessment from a single CT study, providing greater overall clinical value.

Pricing & Value

Cardiac CT Function Software Application

Tool B, the Cardiac CT Function Software Application, provides transparency regarding its pricing model, detailing a flexible subscription, volume-aligned pricing, and pay-per-process options for certain modules. This allows potential customers to better understand and evaluate the cost-effectiveness. In contrast, Tool A, Autoplaque, does not disclose any pricing information, making it difficult to assess its value proposition.

Enterprise Readiness

Cardiac CT Function Software Application

Tool B demonstrates superior enterprise readiness through its explicit support for on-premise deployment, seamless integration with hospital PACS via DICOM connectivity, and vendor-neutral compatibility. It also addresses HIPAA compliance more directly and offers client/server deployment for centralized user management. Tool A, being workstation-based, appears less geared for large-scale enterprise integration.

Innovation

Tie

Both tools showcase significant innovation by leveraging AI/ML for advanced cardiac imaging analysis. Autoplaque's automated quantitative analysis of coronary plaque and luminal stenoses for heart attack risk prediction is highly innovative. Similarly, Tool B's comprehensive application of AI/ML to both cardiac function metrics and coronary plaque analysis within a unified platform also represents substantial innovation in automating complex cardiac assessments.

Support & Docs

Cardiac CT Function Software Application

Tool B, developed by Circle Cardiovascular Imaging, offers a robust support ecosystem including dedicated technical support, comprehensive online documentation, archived tutorials, and workshops. This level of structured support is characteristic of a commercial software vendor. Tool A, developed by a medical center, does not publicly detail a comparable level of commercial support or documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Autoplaque Cardiac CT Function Software Application
Name Autoplaque Cardiac CT Function Software Application
Company Cedars-Sinai Medical Center: AIM Circle Cardiovascular Imaging
Description Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. Circle Cardiovascular Imaging's Cardiac CT Function Software Application uses AI/ML to analyze multi-phase, multi-slice cardiovascular CT angiography images, segmenting cardiac structures and quantifying key function metrics like ejection fraction and volumes. It is part of the cvi42 platform, enhancing diagnostic workflows and patient care.
Key Features AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area AI/ML algorithms for cardiac structure segmentation; Quantification of cardiac function metrics (EDV, ESV, SV, EF, CO, CI, LV myocardial mass); Manual and semi-automatic heart segmentation (LV, RV); 2D/3D visualization and multiplanar reconstruction; Integrated reporting with infographics and screenshots; Vendor-neutral solution (supports various operating systems and scanner types); Full DICOM and PACS connectivity; Coronary plaque analysis (total, calcified, non-calcified, low attenuation)

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and Cardiac CT Function Software Application.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Autoplaque primarily focuses on AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction. The Cardiac CT Function Software Application uses AI/ML to analyze multi-phase CT angiography images, segmenting cardiac structures and quantifying key function metrics like ejection fraction and volumes, while also offering coronary plaque analysis.
Autoplaque offers AI-powered quantitative analysis, detection, and characterization of atherosclerotic plaque, along with measurement of luminal stenoses. The Cardiac CT Function Software Application provides coronary plaque analysis including total, calcified, non-calcified, and low attenuation plaque.
Autoplaque's description focuses on the analysis of coronary plaques and luminal stenoses and does not list cardiac function metrics. The Cardiac CT Function Software Application explicitly quantifies cardiac function metrics such as EDV, ESV, SV, EF, CO, CI, and LV myocardial mass.
AI Tool Finder
AI-powered search. Results may not be comprehensive.